Log In
BCIQ
Print this Print this
 

ProFlu+

  Manage Alerts
Collapse Summary General Information
Company Hologic Inc.
DescriptionTest that detects 4 common respiratory viruses
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect and differentiate influenza A virus, influenza B virus, and respiratory syncytial virus (RSV); Diagnose respiratory viruses including the flu
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$85.0M

$60.0M

$25.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/02/2009

$85.0M

$60.0M

$25.0M

Get a free BioCentury trial today